Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: a three-part randomized, double-blind, placebo-controlled trial

Niklas Walther, Robert Schultz-Heienbrok, Heino Staß, Victor M. Corman, Nils C. Gassen, Marcel A. Müller, Christian Drosten, Martin Witzenrath, Hweeling Lee, Maximilian G. Posch
doi: https://doi.org/10.1101/2024.05.06.24306928

Article usage

Article usage: May 2024 to March 2025

AbstractFullPdf
May 20243131272
Jun 2024872346
Jul 202477258
Aug 202457223
Sep 202460227
Oct 202474868
Nov 202465065
Dec 2024691347
Jan 202595480
Feb 2025433241
Mar 2025184512
Back to top
Posted May 06, 2024.
Download PDF
Data/Code
Email
Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: a three-part randomized, double-blind, placebo-controlled trial
Niklas Walther, Robert Schultz-Heienbrok, Heino Staß, Victor M. Corman, Nils C. Gassen, Marcel A. Müller, Christian Drosten, Martin Witzenrath, Hweeling Lee, Maximilian G. Posch
medRxiv 2024.05.06.24306928; doi: https://doi.org/10.1101/2024.05.06.24306928
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area